Categories AlphaGraphs, Earnings, Technology
Earnings: Sprint Corp. slips to loss in Q1; revenue beats
Telecommunications firm Sprint Corporation (NYSE: S) reported a net loss for the June quarter, compared to profit last year. The results came in above analysts’ estimates and the company’s stock was up during Friday’s pre-market session.
The Overland Park, Kansas-based company reported a net loss of $111 million or $0.03 per share for the first quarter, compared to a profit of $176 million or $0.04 per share in the corresponding period of last year. Analysts were looking for a slightly wider loss.
Net revenues were broadly flat $8.14 billion. The top-line, however, topped the expectations. Postpaid net additions were 134,000 during the quarter. Total wireless service revenue declined 3% annually.
Net Additions
Net additions of 262,000 in data devices were partially offset by net losses of 128,000 in the phone segment. Postpaid gross additions in digital channels climbed about 50% year-over-year. Meanwhile, average postpaid accounts were broadly unchanged year-over-year.
Also see: Verizon Q2 profit beats Street view on wireless strength
“While we delivered good results in the first quarter relative to expectations, the business still faces several structural headwinds and I remain convinced the merger with T-Mobile is the best outcome for our customers, employees, industry and all stakeholders,” said Sprint CEO Michel Combes.
T-Mobile Merger
During the quarter, the company launched voice-to-digital tools that allow customers calling with specific issues to use a digital self-service option The management said it expects to obtain the FCC’s approval for its planned merger with rival telecom firm T-Mobile (TMUS) in the near term.
Shares of Sprint hit a two-year high last month, after gaining 19% since the beginning of the year. In the past twelve months, they grew 28%. The stock closed the previous session lower.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
